SciELO - Scientific Electronic Library Online

 
vol.20 issue1Mentalization capacity study in Focalised Therapy Group for violent adolescentsRelación terapéutica: estudio en población de estudiantes universitarios author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO

Share


Anuario de investigaciones

On-line version ISSN 1851-1686

Abstract

D'ALESSANDRO, Fabián et al. Empiric evidence about combined psychotherapy and pharmcological treatment of social phobia (social anxiety disorder). Anu. investig. [online]. 2013, vol.20, n.1, pp.29-38. ISSN 1851-1686.

Combined treatment (CT) for patients with social anxiety disorder or social phobia is quite common in clinical practice. However, the superiority of TC over psychotherapy and/or pharmacotherapy as monotherapy is still not clear. Over the last few years, several clinical studies that evaluate the effcacy of CT in social phobia have been published. A systematic review of clinical studies about CT in social phobia was carried out in this article in the following datábase: EBSCO, PubMed, Cochrane Collaboration and the "Portal de Búsqueda de la Biblioteca Virtual en Salud". We found 8 randomized controlled studies. There is a superiority of CT over monotherapy in most of them, either psychotherapeutic or pharmacologic. We discuss these fndings in terms of the methodological limitations of all clinical studies found, and based on clinical suggestions derived therefrom. Given this, it is concluded that there is evidence about the superiority of CT over monotherapy in social phobia treatment, although caution in generalizing this conclusión is suggested.

Keywords : Combined treatment; Psychotherapy; Pharmacotherapy; Social phobia; Social anxiety disorder.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License